Company profile: Insitro
1.1 - Company Overview
Company description
- Provider of an ML-driven drug discovery platform integrating in vitro cellular and clinical data; therapeutic programs in metabolism, oncology, and neuroscience; machine learning for disease redefinition and intervention identification; aggregation of clinical and phenotypic data; automated labs generating multimodal phenotypic cellular data; and pipelines for in-house and partnered programs.
Products and services
- ML-driven Drug Discovery Platform: Multi-modal platform integrating in vitro cellular data with clinical datasets to accelerate new medicine discovery and development using machine learning
- Therapeutic Program Development: Data-informed programs in metabolism, oncology, and neuroscience that leverage insights from the ML-driven platform to advance drug discovery and development
- Machine Learning for Disease Redefinition: Computational modeling that constructs AI and machine-learning models to interpret disease states and identify therapeutic intervention opportunities
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Insitro
OmicEra
HQ: Germany
Website
- Description: Provider of proteomics and artificial intelligence (AI) capabilities for medical diagnostics, leveraging high-end mass spectrometry-based proteomics to improve human health, with transparency, reproducible results, and open-source software development at its core.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OmicEra company profile →
Qualtrax
HQ: United States
Website
- Description: Provider of intranet-based quality and document control solutions supporting regulatory requirements in regulated industries. Offerings include Ideagen Quality Management for document control, workflow automation, and risk management, and specialized Food & Beverage editions focused on supplier management, risk assessment, and compliance with food safety standards. Based in Christiansburg, Virginia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Qualtrax company profile →
4G Clinical
HQ: United States
Website
- Description: Provider of software and services for clinical drug trials focused on randomization and trial supply management (RTSM), offering Prancer RTSM for complex and simple study randomization and supply, 4C Supply to manage supply chain risks, project patient demand, and adapt to protocol amendments, and Prancer RTSM Rand-Only for randomization-only patient tracking with blinded/unblinded site users.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 4G Clinical company profile →
Scientist.com
HQ: United States
Website
- Description: Provider of AI-powered public and private marketplaces that connect buyers and sellers of scientific research services for outsourced R&D, simplifying sourcing and reducing time, cost and risk. Solutions include AI-driven procurement with instant quotes and supplier comparisons, 24/7 Research Concierge, COMPLi for secure sourcing of regulated services, enterprise tools from CROs, a supplier platform, and VERIF.i for transparency.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Scientist.com company profile →
Author-it
HQ: United States
Website
- Description: Provider of enterprise software for authoring, content management, publishing, and localization, including Author-it CCMS for creating, managing, and multi-channel publishing of technical documentation and eLearning; Docuvera for structured authoring in life sciences and pharmaceutical industries; cloud-based eLearning authoring with xAPI/SCORM and LMS integration; plus support, implementation, and consulting services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Author-it company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Insitro
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Insitro
2.2 - Growth funds investing in similar companies to Insitro
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Insitro
4.2 - Public trading comparable groups for Insitro
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →